2004. to control disease replication and slow down disease progression but also attract attention to the fact that actually simple immunogens that eventually contribute to protecting activity can transiently exacerbate subsequent lentiviral infections. Failure to develop efficacious AIDS vaccines based on the major structural parts Env and Gag of human being immunodeficiency disease type 1 (HIV-1) offers prompted investigation of a variety of unprecedented strategies, including the use of the small regulatory proteins of the disease as immunogens. Although several such proteins are targeted by immune reactions during natural HIV-1 illness (51), the second option attempts possess primarily focused on the accessory protein Tat, which has a number of attractive properties under this respect (examined in referrals 6 and 45). These attempts, however, have generated conflicting findings. Indeed, Meta-Topolin in Tat-vaccinated nonhuman primates, some organizations have observed considerable levels of safety and proposed Meta-Topolin that native or inactivated Tat should be included in long term multicomponent HIV-1 vaccines (5, 11, 18, 20, 21, 34, 35), while others have failed to demonstrate appreciable beneficial effects (1, 28, 32, 45). Among the models being used in the struggle to conceive and validate rational approaches to AIDS immune prophylaxis (14), feline immunodeficiency disease (FIV) is definitely of particular interest because it circulates widely among domestic pet cats, where it sustains infections and generates pathological effects much like HIV-1 in humans, thus allowing for vaccine tests in the field as well as with the laboratory (4). FIV lacks a gene and its related transactivation response element. It does, however, code for an accessory 77- or 78-amino-acid (aa) protein designated ORF-A or ORF-2, which was in the beginning considered Tat-like because of its ability to transactivate viral transcription Meta-Topolin at low levels but was consequently shown to share several properties with HIV-1 Vpr, including nuclear localization and induction of G2 cell cycle Comp arrest (16). Importantly, deletion of the ORF-A gene results in the production of viruses impaired for replication in lymphocytes and with reduced virulence. These characteristics provide ORF-A-deleted constructs with appropriate prerequisites for vaccine candidates (15, 36, 38). On the basis of these premises and the hypothesis that a tailored immune response against the ORF-A protein would effect replication of wild-type (wt) disease, we evaluated the potential of this protein as a protecting immunogen by immunizing pet cats with recombinant protein in alum or with DNA only or by a DNA prime-protein boost protocol. All the immunized animals produced various levels of anti-ORF-A antibodies, and most also generated transiently measurable ORF-A-specific T-cell reactions. Upon challenge having a moderate dose of ex lover vivo homologous FIV, the ORF-A-immunized animals showed an enhancement of acute-phase illness relative to settings who experienced received parallel programs of alum adjuvant only or bare vector DNA. Despite this initial paradoxical effect, the ORF-A-immunized animals exhibited reduced average post-acute-phase plasma FIV lots and slower decrease of circulating CD4+ T lymphocytes than the control animals did. Efforts to understand the reasons for the exacerbation of acute-phase illness observed following ORF-A immunization will also be explained. MATERIALS AND METHODS Cloning of ORF-A into eukaryotic and prokaryotic manifestation vectors. Both the DNA and protein ORF-A immunogens were from p34TF10 Meta-Topolin (nucleotides [nt] 5992 to 6228, referred to as the Petaluma strain of FIV [FIVPET], GenBank accession quantity “type”:”entrez-nucleotide”,”attrs”:”text”:”NC_001482″,”term_id”:”9626701″,”term_text”:”NC_001482″NC_001482), after the quit codon at position 6120 had been replaced with Trp, the residue present at this position in wild-type FIV. ORF-A was amplified by PCR using primers bearing appropriate restriction Meta-Topolin sites and then inserted into.